The evolving treatment of anal cancer: How are we doing?

Archives of Surgery

Volumn 136, Issue 8, 2001, Pages 886-891

  Whiteford, M H ^a   Stevens K R , Jr ^a   Oh, S ^a   Deveney, K E ^a   Billingham, R ^a   O'Connell, T X ^a   Schecter, W P ^a   Wren, S M ^a   Schrock, T R ^a   De Virgilio, C ^a   Russell, T R ^a   Deveney, ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANUS CANCER; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COLOSTOMY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; OUTCOMES RESEARCH; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; SURVIVAL TIME;

EID: 0034904103     PISSN: 00040010     EISSN: None     Source Type: Journal    
DOI: 10.1001/archsurg.136.8.886     Document Type: Article

References (9)

1. Perianal and anal canal neoplasms
2. Anal cancer
3. Anal neoplasms
4. Considine B Combined therapy for cancer of the anal canal: A preliminary report
5. Combined preoperative radiation and chemotherapy for squamous cell carcinoma of the anal canal
6. Epidermoid anal cancer: Results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin
7. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: Results of a phase III randomized intergroup study
8. Concomitant radiotherapy and chemotherapy is superior to radiotherapy alone in the treatment of locally advanced anal cancer: Results of a phase III randomized trial of the European Organization for Research and Treatment of Cancer Radiotherapy and Gastrointestinal Cooperative Groups